CDH2 and neoplasm: N-cadherin suppresses E-cadherin transcription, while VE-cadherin promotes epithelial-to-mesenchymal transition (EMT) and enhances tumor invasiveness through the transforming growth factor-beta (TGF-β) pathway [58,59].